LYTIR

Company · LRMR

Larimar Therapeutics, Inc.

Nasdaq's symbol directory lists LRMR on Nasdaq as “Larimar Therapeutics, Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 10 occasions ($569K); 1 filing by holders of 5% or more; 3 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 55, No. 54, No. 53, No. 52, No. 51, No. 50, No. 49

Insider purchases and sales, by month (last 12 months)Insider purchases: $569K in total; Insider sales: $0 in total.Jul: Insider purchases $167KNov: Insider purchases $402KDecJanFebMarAprMayJunJulAugSepOctNov$402K
Insider purchases above the line: $569KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Hamilton Thomas Edward bought on 2 days latest Nov 12, 2026 bought $354K
  2. Celano Michael, Chief Financial Officer bought on 1 day latest Nov 11, 2026 bought $50K
  3. BEN-MAIMON CAROLE, President and CEO bought on 1 day latest Nov 11, 2026 bought $50K
  4. Harlow John B. Jr., President and COO bought on 1 day latest Nov 11, 2026 bought $50K
  5. Frank E. Thomas bought on 1 day latest Nov 11, 2026 bought $22K
  6. Shankar Gopi, Chief Development Officer bought on 1 day latest Nov 11, 2026 bought $14K
  7. SHERMAN JEFFREY W bought on 1 day latest Nov 16, 2026 bought $10K
  8. Clayton Russell, Chief Medical Officer bought on 1 day latest Nov 16, 2026 bought $10K
  9. Truitt Joseph bought on 1 day latest Nov 11, 2026 bought $10K
Every trade (10)
  1. BUYSHERMAN JEFFREY W bought Nov 16, 2026 3,289 shares filing $10K
  2. BUYClayton Russell, Chief Medical Officer bought Nov 16, 2026 3,322 shares filing $10K
  3. BUYHamilton Thomas Edward bought Nov 12, 2026 70,000 shares filing $187K
  4. BUYCelano Michael, Chief Financial Officer bought Nov 11, 2026 18,460 shares filing $50K
  5. BUYBEN-MAIMON CAROLE, President and CEO bought Nov 11, 2026 18,050 shares filing $50K
  6. BUYHarlow John B. Jr., President and COO bought Nov 11, 2026 17,800 shares filing $50K
  7. BUYFrank E. Thomas bought Nov 11, 2026 8,000 shares filing $22K
  8. BUYShankar Gopi, Chief Development Officer bought Nov 11, 2026 5,000 shares filing $14K
  9. BUYTruitt Joseph bought Nov 11, 2026 3,500 shares filing $10K
  10. BUYHamilton Thomas Edward bought Jul 6, 2026 50,000 shares filing $167K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. RTW Investments, LP filed Nov 16, 2026 Schedule 13G passive filing 5.6%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 16, 2026
  2. Results of operations and financial condition; Other events filing Nov 9, 2026
  3. Departure or appointment of directors or officers filing Sep 29, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.